ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials

BACKGROUND: Development of new therapies for Alzheimer's disease (AD) is increasingly focused on more mildly affected populations, and requires new assessment and outcome strategies. Patients in early stages of AD have mild cognitive decline and no, or limited, functional impairment. To respond...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Neurol Neurosurg Psychiatry
Autori principali: Wang, Jinping, Logovinsky, Veronika, Hendrix, Suzanne B, Stanworth, Stephanie H, Perdomo, Carlos, Xu, Lu, Dhadda, Shobha, Do, Ira, Rabe, Martin, Luthman, Johan, Cummings, Jeffrey, Satlin, Andrew
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2016
Soggetti:
Neurodegeneration
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5013117/
https://ncbi.nlm.nih.gov/pubmed/27010616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2015-312383
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi